Committed Funding. Genentech is committed to paying Constellation up to a maximum of [**] U.S. Dollars ($[**]) over the Initial Research Term to fund [**] Constellation FTEs to conduct the Research Collaboration in accordance with the Research Plan. In addition, if Genentech extends the Research Collaboration for the First Extended Research Term, Genentech shall pay Constellation [**] U.S. Dollars ($[**]) to fund [**] Constellation FTEs to conduct the Research Collaboration in accordance with the Research Plan during such First Extended Research Term. Genentech shall pay Constellation for Constellation’s FTEs at the FTE Rate. Genentech shall owe FTE support payments to Constellation quarterly, in advance (each such payment, an “FTE Payment”), in the amount of
Committed Funding. The Committed Funding contribution of the ICB and the Council to the Pooled Fund shall be as set out in Schedule 3 – Committed Funding.
Committed Funding. The Company shall have received an aggregate amount of cash no less than $20,000,000 from the offering of its Company Convertible Notes.
Committed Funding. £10,601,222, which includes the health element of the budget at £6,115,622. Additional funding, available from December 2022 to 31st March 2023, to support timely and safe discharge from hospital into the community by reducing the number of people delayed in hospital awaiting social care. The following services will be commissioned under this scheme: WS001 - Additional PTS Resource £60,000 WS002 - Self-funder Placement Support Service (e.g., CHS) £75,000 WS003 - Health Care Assistants Providing Additional Care Capacity in Home First £160,000 WS004 - Block Contracted Nursing Home Beds for Patients Awaiting Onward Placement (Not Discharge to Assess) £780,000 WS005 - Personal Health Grants for Hospital Discharge Patients £60,000 WS006 - Additional Social Work Capacity to Undertake Care Act Assessments Within the Discharge Capacity to Move People On £294,498 WS007 - Additional B6 Nurse Locum to Support Clinical Assessment in HF £333,540 WS008 - Additional DISCOs at UHSx £108,980 WS009 - Complex Discharge Coordinator Admin Role to Support HF Pathway £24,740 WS014 - Dedicated Senior Decision Maker Weekend Discharge Team £173,866 WS015 - Adult Hospice Non-Specialist End of Life Care (EoLC) Bed Scheme £664,337 WS016 - Block Purchase Nursing Home Beds £351,000 WS027 - Enhancing MH Discharge Hub and Placement Finding Team £150,000 WS028 - Acute/Community Co-ordinators Posts £70,000 WS029 - High Intensity Users Care Planning £54,900 WS034 - Same Day Discharge Front Door Practitioner £120,000 WS035 - Smartwatch Technology Enabled Rehabilitation Following Hip Fracture in Older Adults £13,636 WS037 - EoLC/Palliative Discharge Co-ordinator £45,000 WS040 - Horsham XxXxxxxxx - Additional HCAs to Provide Hospice at Home £83,053 WS041 - Additional Infrastructure Support to ECHO £36,610 WS043 - SaSH Same Day Emergency Care Discharge Team £124,998 WS044 - Health Care Assistants Providing Additional Care Capacity in Home First (Additional to WS003) £160,000 WS045 - Expansion of SaSH at Home £64,000 WS046 - Additional Qualified Social Work Assessors (Locums) £200,000 £4,208,158 The Commissioning Partner will be NHS Sussex Integrated Care Board. £4,208,158. Additional funding, available from December 2022 to 31st March 2023, to support timely and safe discharge from hospital into the community by reducing the number of people delayed in hospital awaiting social care. The following services will be commissioned under this scheme: WS018 - Hospital Discharge Care Additional Hours £3...
Committed Funding. Borrower has available (as specified in the Borrower’s 2010-2014 Capital Program (as amended to the date hereof) including funding available under the Grant Agreements and this Agreement) funding which is sufficient to complete the Positive Train Control Project based on Borrower’s current projection of the necessary capital expenditures consisting of amounts specified in the Borrower’s 2010-2014 Capital Program (as amended to the date hereof) including funding available under Grant Agreements and this Agreement, the Borrower’s anticipated 2015-2019 Capital Program, and amounts permitted to be borrowed as Subordinated Indebtedness under the Transportation Resolution.
Committed Funding. Funding for the 2021-2022 school year is in the amount of $7,500.00. Funds will be disbursed to the LEA from The Intermediate Unit One (fiscal agent of PaTTAN Pittsburgh). Up to half of the funds will be disbursed upon verification of the completion of December - February activities. The remaining funds will be disbursed no later than June 30, 2022 upon verification of the remaining agreements.
Committed Funding. Neovacs and Stellar hereby undertake to provide the Company, pro rata to their interest in the share capital of the Company, with any additional financing beyond their Initial Contributions, *** in connection with the implementation of the Project to satisfy (i) the Company's financing needs as identified and agreed between the Parties and (ii) any capital contribution required under applicable Law (together the "Committed Funding"). If Neovacs or Stellar does not contribute its pro-rata share of the Committed Funding, the other Party shall have the right to provide all or part of the required Committed Funding, with consequent dilution of the non-contributing Party’s shareholding, in accordance with the provisions of Section 4.3(b) which should apply mutatis mutandis.
